"VSports" Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma
- PMID: 12402302
- PMCID: PMC4122310
- DOI: 10.1002/ijc.10719
Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma
Abstract
The molecular events that precede the development of osteosarcoma, the most common primary malignancy of bone, are unclear, and concurrent molecular and genetic alterations associated with its pathogenesis have yet to be identified. Recent studies suggest that activation of beta-catenin signaling may play an important role in human tumorigenesis. To investigate the potential role of beta-catenin deregulation in human osteosarcoma, we analyzed a panel of 47 osteosarcoma samples for beta-catenin accumulation using immunohistochemistry. Potential activating mutations were investigated by sequencing exon 3 of the beta-catenin gene in genomic DNA isolated from tumor samples. Our findings revealed cytoplasmic and/or nuclear accumulation of beta-catenin in 33 of 47 samples (70. 2%); however, mutation analysis failed to detect any genetic alterations within exon 3, suggesting that other regulatory mechanisms may play an important role in activating beta-catenin signaling in osteosarcoma. In our survival analysis, beta-catenin deregulation conferred a hazard ratio of 1. 05, indicating that beta-catenin accumulation does not appear to be of prognostic value for osteosarcoma patients. When analyzed against other clinicopathologic parameters, beta-catenin accumulation correlated only with younger age at presentation (26. 4 vs. 39. 8 years). Nevertheless, our results demonstrate that the deregulation of beta-catenin signaling is a common occurrence in osteosarcoma that is implicated in the pathogenesis of osteosarcoma VSports手机版. .
Copyright 2002 Wiley-Liss, Inc.
Figures


References
-
- Mirra JM, Picci P, Gold RH. Bone tumors: clinical, radiologic, and pathologic correlations. Philadelphia: Lea & Febiger; 1989.
-
- Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G. Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience. Cancer. 1992;69:698–708. - "V体育官网" PubMed
-
- Danckwerth F, Wuisman P, Ritter J, Blasius S, Jurgens H, Ozaki T, Winkelmann W. Osteosarkom bei zwei Geschwistern. Eine kasuistische Darstellung. Klin Padiatr. 1995;207:298–301. - PubMed
-
- Chauveinc L, Mosseri V, Quintana E, Desjardins L, Schlienger P, Doz F, Dutrillaux B. Osteosarcoma following retinoblastoma: age at onset and latency period. Ophthalmic Genet. 2001;22:77–88. - "V体育平台登录" PubMed
-
- Miller CW, Aslo A, Won A, Tan M, Lampkin B, Koeffler HP. Alterations of the p53, Rb and MDM2 genes in osteosarcoma. J Cancer Res Clin Oncol. 1996;122:559–565. - PubMed
Publication types (VSports最新版本)
- "V体育ios版" Actions
MeSH terms
- VSports最新版本 - Actions
- V体育官网 - Actions
- VSports app下载 - Actions
- Actions (V体育ios版)
- "V体育官网" Actions
- "V体育2025版" Actions
- "V体育官网入口" Actions
- "V体育安卓版" Actions
- "V体育安卓版" Actions
- "VSports最新版本" Actions
- "V体育安卓版" Actions
"V体育官网" Substances
- Actions (V体育2025版)
- "V体育2025版" Actions
Grants and funding
VSports最新版本 - LinkOut - more resources
Full Text Sources
Medical
Miscellaneous